Celgene

PD-L1 Inhibitor: durvalumab

Biodrugs/ Drugs
Blood and Lymphatic systems
Cancer
Myelodysplastic Syndromes (MDS) Acute Myeloid Leukemia (AML)
2Phase II, 1Phase I